期刊文献+

蒙古沙鼠非酒精性脂肪性肝病模型的建立与评价 被引量:6

Establishment and Evaluation of Animal Models of Nonalcoholic Fatty Liver Disease in Mongolian Gerbils
下载PDF
导出
摘要 目的初步建立并评价蒙古沙鼠非酒精性脂肪性肝病模型。方法选取20只雄性蒙古沙鼠,按体重随机分为模型组及正常对照组,分别予以高脂饲料及正常对照饲料喂养。每周观察两组沙鼠的饮食、体重、皮毛、活动情况、精神状态等一般情况的变化;造模12周后获取血液及肝脏标本,用于血清转氨酶、血脂、血糖等指标的检测以及肝脏病理学的观察,从而评价模型的成模情况。结果模型组的体重明显重于同期正常对照组的体重;造模12周后,模型组血清丙氨酸氨基转移酶、门冬氨酸氨基转移酶、甘油三脂、总胆固醇、血糖等指标均明显高于正常对照组;病理学检查发现,模型组肝脏出现较为明显的脂肪变性,而正常对照组肝脏无异常发现。结论运用高脂饲料喂养蒙古沙鼠12周初步复制了非酒精性脂肪性肝病模型,该模型能较好地模拟出人类非酒精性脂肪性肝病发病的具体病理生理过程以及肝脏病理学变化。 Objective To establish and evaluate the animal model of nonalcoholic fatty liver disese in Mongolian gerbils. Methods Twenty male Mongolian gerbils were randanfly divided into two groups by weight: model group and normal control group, which were treated with high-fat diet and normal control diet respectively. The general status changes in the two group gerbils were observed, including diet, weight, fi.lr, activities and mental status. Twelve weeks after modeling, the blood and liverwere collected to be used as specimen for the detection of serum transaminase, blood fat and blood sugar and the observation of liver histopathology so as to evaluate the modds. Results The weight in model group was obviously higher than in the control group in the same period. Twelve weeks after modeling, the levels of serum alanine aminotransferase, aspartic acid aminotransferase, triglyceride, total bilirubin and blood sugar in the model group were all significantly higher than in the control group. There was obvious liver fatty degeneration in the model group by pathological detection. But there were no obvious changes in the control group. Condusions Mongolian gerbils in the model group fed with high fat diet can develop a potential model of nonalcoholic fatty liver disease, the model could simulate better the pathologic physiology process of the humane nonalcoholic fatty liver disease and the pathological changes in the liver.
出处 《浙江预防医学》 2007年第11期1-2,7,共3页 Zhejiang Journal of Preventive Medicine
关键词 非酒精性脂肪性肝病 蒙古沙鼠 动物模型 Nonalcoholic fatty liver disease Mongolian gerbils Animal model
  • 相关文献

参考文献8

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 2Fan JG,Zhu J,Li XJ,et al.Prevalence of and risk factors for fatty liver in a general population of Shanghai,China[ J].J Hepatol,2005,43 (3):508-514.
  • 3Jimba S,Nakagami T,Takahashi M,et al.Prevalence of nonalcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults[ J ].Diabet Med,2005,22 (9):1141-1145.
  • 4Reid AE.Nonalcoholic steatohepatitis[J] Gastroenterology,2001,121 (3):710-723.
  • 5Church TS,Kuk JL,Ross R,et al.Association of cardiorespiratory fitness,body mass index,and waist circumference to nonalcoholic fatty liver disease[J].Gastroenterology,2006,1 30 (7):2023-2030.
  • 6Bellentani S,Saccoccio G,Masutti F,et al.Prevalence of and risk factors for hepatic steatosis in Northern Italy[J].Ann Intern Med,2000,132 (2):1121-117.
  • 7Ioannou GN,Boyko EJ,Lee SP.The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002[J].Am J Gastroenterol,2006,101 (1):76-82.
  • 8Clark JM,Brancati FL,Diehl AM.Nonalcoholic fatty liver disease[J].Gastroenterology,2002.122 (6):1649-1657.

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1512

同被引文献44

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部